Bcg

BCG (Bacillus Calmette-Guérin) is a bacterial preparation used primarily for intravesical therapy. It is often associated with bladder cancer treatment and may help stimulate the immune system.

BCG is commonly used in the treatment of bladder cancer. It is administered intravesically, meaning it is introduced directly into the bladder. This approach is designed to target cancer cells within the bladder. BCG therapy is often considered for patients with certain types of bladder cancer to help prevent recurrence.

When used as directed, BCG may cause localized reactions such as bladder irritation, which can lead to symptoms like frequent urination or discomfort. Some individuals may experience flu-like symptoms, including fever or fatigue, following treatment. These effects are generally temporary and should be discussed with a healthcare provider.

BCG should be handled with care to avoid contamination. It is important to follow proper administration procedures to minimize the risk of infection. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting BCG therapy.

BCG may interact with certain medications or treatments that affect the immune system. It is advisable to discuss all current medications with a healthcare provider before starting BCG therapy. Additionally, alcohol consumption should be avoided during treatment to reduce the risk of side effects.